AIxCrypto Holdings, Inc.(AIXC)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-06-22 | Poirier Michael S. Chairman and CEO | Purchase | +30,000 | +17.73%199,202 | $0.57 | $17,100 | View SEC filing | |
| 2022-06-15 | BROIDRICK AMY S. President/CSO | Purchase | +30,000 | +666.67%34,500 | $0.62 | $18,600 | View SEC filing | |
| 2021-08-20 | Kruger Kurt H Director | Purchase | +8,000 | +80.00%18,000 | $1.23 | $9,800 | View SEC filing | |
| 2021-04-26 | BROIDRICK AMY S. EVP, Chief Strategy Officer | Purchase | +4,500 | +100.00%4,500 | $2.03 | $9,135 | View SEC filing | |
| 2021-04-21 | Poirier Michael S. Chairman, CEO & President | Purchase | +11,005 | +100.00%11,005 | $1.80 | $19,809 | View SEC filing | |
| 2021-04-19 | Lotz Christopher L. Vice President of Finance, CFO | Purchase | +2,700 | +27.44%12,541 | $1.86 | $5,022 | View SEC filing | |
| 2020-12-30 | Kruger Kurt H Director | Purchase | +4,000 | +66.67%10,000 | $2.94 | $11,740 | View SEC filing | |
| 2020-11-23 | Kruger Kurt H Director | Purchase | +6,000 | +100.00%6,000 | $3.48 | $20,894 | View SEC filing | |
| 2020-03-16 | Doyle Noah Director | Sale | -500,000 | -40.34%739,327 | $0.22 | $110,000 | View SEC filing | |
| 2020-03-13 | Ritter Ira E. COB, CSO | Sale | -18,750 | -18.66%81,727 | $0.38 | $7,043 | View SEC filing | |
| 2020-03-13 | Ritter Andrew J CEO and President | Sale | -18,750 | -18.66%81,727 | $0.38 | $7,043 | View SEC filing | |
| 2018-11-07 | FOEHR MATTHEW W Director | Purchase | +115,384 | +100.00%115,384 | N/A | N/A | View SEC filing | |
| 2018-09-19 | FOEHR MATTHEW W Director | Purchase | +19,751 | +564.31%23,251 | $2.04 | $40,292 | View SEC filing | |
| 2018-08-20 | FOEHR MATTHEW W Director | Purchase | +19,751 | +56.43%54,751 | $2.04 | $40,292 | View SEC filing | |
| 2017-10-27 | Ritter Andrew J President | Purchase | +375,000 | +45.88%1,192,272 | N/A | N/A | View SEC filing | |
| 2017-10-27 | Ritter Ira E. Exec. Chairman, CSO | Purchase | +375,000 | +45.88%1,192,272 | N/A | N/A | View SEC filing | |
| 2017-10-27 | Doyle Noah Director, 10% Owner | Purchase | +10,000,000 | +488.33%12,047,804 | N/A | N/A | View SEC filing | |
| 2017-10-27 | Javelin Venture Partners, L.P. 10% Owner | Purchase | +10,000,000 | +488.33%12,047,804 | N/A | N/A | View SEC filing | |
| 2017-05-18 | FOEHR MATTHEW W Director | Purchase | +18,000 | +105.88%35,000 | $0.62 | $11,155 | View SEC filing | |
| 2017-05-12 | Step Michael D CEO | Purchase | +13,000 | +35.14%50,000 | $0.62 | $8,007 | View SEC filing | |
| 2017-02-28 | Step Michael D CEO | Purchase | +10,000 | +37.04%37,000 | $2.65 | $26,480 | View SEC filing | |
| 2016-02-24 | Ritter Ira E. Exec. Chairman, CSO | Purchase | +6,250 | +100.00%6,250 | $1.60 | $10,000 | View SEC filing | |
| 2016-02-24 | Ritter Andrew J President | Purchase | +6,250 | +100.00%6,250 | $1.60 | $10,000 | View SEC filing | |
| 2016-01-11 | FOEHR MATTHEW W Director | Purchase | +13,000 | +325.00%17,000 | $1.64 | $21,320 | View SEC filing | |
| 2016-01-08 | Step Michael D CEO | Purchase | +27,000 | +100.00%27,000 | $1.48 | $39,960 | View SEC filing |
1-25 of 29